Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001817713-21-000002
Filing Date
2021-04-30
Accepted
2021-04-30 13:59:17
Documents
1
Effectiveness Date
2021-04-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10353
  Complete submission text file 0001817713-21-000002.txt   11461
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-397786 | Film No.: 21876363
SIC: 2834 Pharmaceutical Preparations